數位乳房 X 光攝影市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球數位乳房 X 光攝影市場價值 17 億美元，預計到 2034 年將以 10.4% 的複合年成長率成長至 45 億美元。受全球乳癌發病率上升、早期發現意識增強、政府積極舉措以及影像技術進步的推動，該市場正在快速成長。數位乳房 X 光攝影使醫療保健提供者能夠捕捉乳房組織的高解析度影像，有助於乳癌的早期發現和診斷。此技術廣泛應用於醫院、診斷中心和專科診所等臨床環境。該領域的領先公司包括 GE 醫療、Hologic、西門子醫療、富士膠片控股和荷蘭皇家飛利浦電子公司。市場主要專注於全視野數位乳房 X 光攝影 (FFDM) 和 3D 斷層合成系統等設備，這些設備可提高診斷準確性、減少輻射暴露並改善患者預後。

由於政府支持的篩檢計畫和影像技術的持續進步，數位化和人工智慧乳房鉬靶X光檢查系統的普及率顯著提升。隨著醫療保健行業日益重視以患者為中心的診療，數位化乳房鉬靶X光檢查因其更高的影像精度、更少的診斷錯誤以及更高的患者舒適度而成為首選。此外，乳癌發生率的上升凸顯了早期精準檢測以改善臨床療效的必要性。

2024年，2D全視野數位乳房斷層攝影（2D Full-field Digital Molecular X-ray, DTMS）市場價值11億美元，預計複合年成長率為10.2%，到2034年將達到29億美元。該技術是乳癌診斷不可或缺的一部分，它提供高解析度數位影像，幫助放射科醫生檢測細微異常，例如微鈣化和小腫塊。整合影像解決方案、人工智慧驅動的診斷和全面的乳癌篩檢計劃的使用日益增多，正在促進該領域的成長。影像清晰度的提高有助於發現早期乳癌，從而提高成功干預的幾率並改善患者預後。

2024年，醫院領域佔了48.5%的市場。醫院領域佔最大佔有率，得益於其先進的影像基礎設施以及在乳癌篩檢和診斷中發揮關鍵作用的熟練放射科醫生。醫院是乳癌治療的核心，這推動了對多模式影像系統和人工智慧整合數位乳房鉬靶X光攝影的需求。此外，新興市場（尤其是亞太、中東和非洲等地區）醫療基礎設施的發展，正在加速先進乳房鉬靶X光攝影技術在醫院環境中的應用，包括2D和3D斷層合成系統。

2024年，美國數位乳房X光檢查市場規模達6.305億美元，其成長主要源自於美國乳癌發生率的上升。隨著對早期精準乳癌檢測的需求不斷成長，對數位乳房X光檢查等先進診斷工具的需求也日益成長。這一趨勢極大地促進了美國市場的成長。

數位乳房 X 光攝影市場的主要參與者包括西門子醫療、通用電氣醫療、荷蘭皇家飛利浦、富士膠片控股和豪洛捷。為了鞏固市場地位，數位乳房 X 光攝影產業的公司正專注於幾項關鍵策略。一種方法是不斷創新影像技術，例如將人工智慧 (AI) 整合到乳房 X 光攝影系統中，以提高診斷準確性和速度。另一項策略是與醫療保健提供者和組織建立合作夥伴關係，以擴大其產品和服務的覆蓋範圍。許多公司也正在投資開發更方便用戶使用、以患者為中心的解決方案，以減少篩檢過程中的不適感，這是患者日益關注的問題。此外，公司正致力於透過瞄準新興市場來擴大市場佔有率，特別是在醫療基礎設施快速發展的地區。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 全球乳癌發生率不斷上升
    • 對早期乳癌檢測的認知不斷提高
    • 政府措施和篩選項目不斷增加
    • 數位乳房X光檢查的技術進步
  • 產業陷阱與挑戰
    • 設備和維護成本高
    • 輻射暴露問題
  • 市場機會
    • 人工智慧預測監控工具和人工智慧整合的採用率不斷上升
• 成長潛力分析
• 監管格局
  • 北美洲
  • 歐洲
  • 亞太地區
• 技術進步
  • 當前的技術趨勢
  • 新興技術
• 供應鏈分析
• 未來市場趨勢
• 定價分析
  • 依產品類型
• 專利分析
• 差距分析
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司市佔率分析
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 關鍵進展
  • 併購
  • 夥伴關係和合作
  • 新產品發布
  • 擴張計劃

第5章：市場估計與預測：依產品類型，2021 - 2034 年

• 主要趨勢
• 2D全視野數位化乳房斷層攝影
• 3D全視野數位化乳房斷層攝影

第6章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 醫院
• 專科診所
• 診斷中心

第7章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 西班牙
  • 義大利
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 沙烏地阿拉伯
  • 南非
  • 阿拉伯聯合大公國

第8章：公司簡介

• Allengers
• Canon
• Carestream
• Fujifilm Holdings
• GE Healthcare
• Genoray
• Hologic
• IDETEC Medical Imaging
• IMS Giotto
• Koninklijke Philips
• Planmed
• Siemens Healthineers
• SINO MDT
• SternMed
• Trivitron Healthcare
• Vannin Healthcare

The Global Digital Mammography Market was valued at USD 1.7 billion in 2024 and is estimated to grow at a CAGR of 10.4% to reach USD 4.5 billion by 2034. This market is growing rapidly, driven by the increasing incidence of breast cancer worldwide, heightened awareness about early detection, proactive government initiatives, and advancements in imaging technology. Digital mammography allows healthcare providers to capture high-resolution images of breast tissue, which aids in early detection and diagnosis of breast cancer. This technology is widely used in clinical environments such as hospitals, diagnostic centers, and specialty clinics. Leading companies in the sector include GE Healthcare, Hologic, Siemens Healthineers, Fujifilm Holdings, and Koninklijke Philips. The market primarily focuses on devices such as full-field digital mammography (FFDM) and 3D tomosynthesis systems, which improve diagnostic accuracy, reduce radiation exposure, and enhance patient outcomes.

The adoption of digital and AI-powered mammography systems has seen a significant rise, aided by government-supported screening programs and continuous advancements in imaging technology. With a growing emphasis on patient-centered care in the healthcare industry, digital mammography is becoming the preferred choice due to its higher image accuracy, reduced diagnostic errors, and enhanced patient comfort. Additionally, the rising prevalence of breast cancer underscores the need for early and accurate detection to improve clinical outcomes.

In 2024, 2D full-field digital mammography tomosynthesis segment was valued at USD 1.1 billion and is expected to grow at a CAGR of 10.2%, to reach USD 2.9 billion by 2034. This technology is integral to breast cancer diagnosis, providing high-resolution digital images that help radiologists detect subtle abnormalities such as microcalcifications and small masses. The increased use of integrated imaging solutions, AI-driven diagnostics, and comprehensive breast cancer screening programs is contributing to the growth of this segment. Enhanced clarity of images helps detect early-stage breast cancer, improving the chances of successful intervention and patient outcomes.

The hospitals segment held 48.5% share in 2024. The hospital segment holds the largest share due to its advanced imaging infrastructure and the presence of skilled radiologists who play a vital role in breast cancer screening and diagnosis. Hospitals are central to breast cancer treatment, which drives the demand for multimodal imaging systems and AI-integrated digital mammography. Furthermore, the development of healthcare infrastructure in emerging markets, especially in regions like Asia-Pacific, the Middle East, and Africa, is accelerating the adoption of advanced mammography technologies within hospital settings, including both 2D and 3D tomosynthesis systems.

U.S. Digital Mammography Market was valued at USD 630.5 million in 2024, with growth largely driven by the increasing prevalence of breast cancer in the country. As the demand for early and accurate breast cancer detection rises, the need for advanced diagnostic tools like digital mammography is growing. This trend significantly contributes to the market's expansion in the U.S.

The key players in the Digital Mammography Market include Siemens Healthineers, GE Healthcare, Koninklijke Philips, Fujifilm Holdings, and Hologic. To strengthen their market position, companies in the digital mammography industry are focusing on a few key strategies. One approach is the continuous innovation of imaging technologies, such as the integration of artificial intelligence (AI) into mammography systems to enhance diagnostic accuracy and speed. Another strategy involves forming partnerships with healthcare providers and organizations to expand the reach of their products and services. Many companies are also investing in developing more user-friendly, patient-centric solutions that reduce discomfort during screenings, which is a growing concern for patients. Additionally, companies are working on expanding their market share by targeting emerging markets, particularly in regions where healthcare infrastructure is rapidly developing.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Data mining sources
  • 1.3.1 Global
  • 1.3.2 Regional/Country
• 1.4 Base estimates and calculations
  • 1.4.1 Base year calculation
  • 1.4.2 Key trends for market estimation
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
• 1.6 Forecast model
• 1.7 Research assumptions and limitations

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis
• 2.2 Key market trends
  • 2.2.1 Regional trends
  • 2.2.2 Product type trends
  • 2.2.3 End use trends
• 2.3 CXO perspectives: Strategic imperatives
  • 2.3.1 Key decision points for industry executives
  • 2.3.2 Critical success factors for market players
• 2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing incidence of breast cancer across the globe
    • 3.2.1.2 Growing awareness regarding early breast cancer detection
    • 3.2.1.3 Rising government initiatives and screening programs
    • 3.2.1.4 Technological advancements in digital mammography
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of equipment and maintenance
    • 3.2.2.2 Radiation exposure concerns
  • 3.2.3 Market opportunities
    • 3.2.3.1 Rising adoption of AI-powered predictive monitoring tools and AI integration
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
  • 3.4.1 North America
  • 3.4.2 Europe
  • 3.4.3 Asia Pacific
• 3.5 Technological advancements
  • 3.5.1 Current technological trends
  • 3.5.2 Emerging technologies
• 3.6 Supply chain analysis
• 3.7 Future market trends
• 3.8 Pricing analysis
  • 3.8.1 By product type
• 3.9 Patent analysis
• 3.10 Gap analysis
• 3.11 Porter's analysis
• 3.12 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Company matrix analysis
• 4.4 Competitive analysis of major market players
• 4.5 Competitive positioning matrix
• 4.6 Key developments
  • 4.6.1 Mergers and acquisitions
  • 4.6.2 Partnerships and collaborations
  • 4.6.3 New product launches
  • 4.6.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 2D full field digital mammography tomosynthesis
• 5.3 3D full field digital mammography tomosynthesis

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Hospitals
• 6.3 Specialty clinics
• 6.4 Diagnostic centers

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 UK
  • 7.3.3 France
  • 7.3.4 Spain
  • 7.3.5 Italy
  • 7.3.6 Netherlands
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Australia
  • 7.4.5 South Korea
• 7.5 Latin America
  • 7.5.1 Brazil
  • 7.5.2 Mexico
  • 7.5.3 Argentina
• 7.6 Middle East and Africa
  • 7.6.1 Saudi Arabia
  • 7.6.2 South Africa
  • 7.6.3 UAE

Chapter 8 Company Profiles

• 8.1 Allengers
• 8.2 Canon
• 8.3 Carestream
• 8.4 Fujifilm Holdings
• 8.5 GE Healthcare
• 8.6 Genoray
• 8.7 Hologic
• 8.8 IDETEC Medical Imaging
• 8.9 IMS Giotto
• 8.10 Koninklijke Philips
• 8.11 Planmed
• 8.12 Siemens Healthineers
• 8.13 SINO MDT
• 8.14 SternMed
• 8.15 Trivitron Healthcare
• 8.16 Vannin Healthcare